{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:48:00Z","timestamp":1792140480556,"version":"4.4.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT 159680"],"award-info":[{"award-number":["PJT 159680"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT 186027"],"award-info":[{"award-number":["PJT 186027"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN162400"],"award-info":[{"award-number":["FRN162400"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Soci\u00e9t\u00e9 Parkinson Qu\u00e9bec"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01201-x","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T09:36:14Z","timestamp":1765618574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Optogenetic-induced \u03b1-synuclein accumulation reveals early synaptic dysfunction in experimental models of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Raquel","family":"Rodriguez-Aller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Romero-Quineche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Morissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Sheta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armen","family":"Saghatelyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abid","family":"Oueslati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"1201_CR1","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","volume":"8","author":"L Maroteaux","year":"1988","unstructured":"Maroteaux, L., Campanelli, J. T. & Scheller, R. H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804\u20132815 (1988).","journal-title":"J. Neurosci."},{"key":"1201_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","volume":"46","author":"M Sharma","year":"2023","unstructured":"Sharma, M. & Burre, J. alpha-Synuclein in synaptic function and dysfunction. Trends Neurosci. 46, 153\u2013166 (2023).","journal-title":"Trends Neurosci."},{"key":"1201_CR3","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1016\/j.cub.2014.08.027","volume":"24","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. alpha-synuclein multimers cluster synaptic vesicles and attenuate recycling. Curr. Biol. 24, 2319\u20132326 (2014).","journal-title":"Curr. Biol."},{"key":"1201_CR4","doi-asserted-by":"publisher","first-page":"E4274","DOI":"10.1073\/pnas.1416598111","volume":"111","author":"J Burre","year":"2014","unstructured":"Burre, J., Sharma, M. & Sudhof, T. C. alpha-Synuclein assembles into higher-order multimers upon membrane binding to promote SNARE complex formation. Proc. Natl. Acad. Sci. USA 111, E4274\u2013E4283 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1201_CR5","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burre","year":"2010","unstructured":"Burre, J. et al. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663\u20131667 (2010).","journal-title":"Science"},{"key":"1201_CR6","doi-asserted-by":"publisher","first-page":"32701","DOI":"10.1073\/pnas.2013652117","volume":"117","author":"M Somayaji","year":"2020","unstructured":"Somayaji, M. et al. A dual role for alpha-synuclein in facilitation and depression of dopamine release from substantia nigra neurons in vivo. Proc. Natl. Acad. Sci. USA 117, 32701\u201332710 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1201_CR7","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.0535-12.2012","volume":"32","author":"D Scott","year":"2012","unstructured":"Scott, D. & Roy, S. alpha-Synuclein inhibits intersynaptic vesicle mobility and maintains recycling-pool homeostasis. J. Neurosci. 32, 10129\u201310135 (2012).","journal-title":"J. Neurosci."},{"key":"1201_CR8","doi-asserted-by":"publisher","first-page":"9364","DOI":"10.1523\/JNEUROSCI.4787-13.2014","volume":"34","author":"KJ Vargas","year":"2014","unstructured":"Vargas, K. J. et al. Synucleins regulate the kinetics of synaptic vesicle endocytosis. J. Neurosci. 34, 9364\u20139376 (2014).","journal-title":"J. Neurosci."},{"key":"1201_CR9","doi-asserted-by":"publisher","first-page":"e00592","DOI":"10.7554\/eLife.00592","volume":"2","author":"J Diao","year":"2013","unstructured":"Diao, J. et al. Native alpha-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2\/VAMP2. Elife 2, e00592 (2013).","journal-title":"Elife"},{"key":"1201_CR10","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/brain\/awad150","volume":"146","author":"P Calabresi","year":"2023","unstructured":"Calabresi, P., Di Lazzaro, G., Marino, G., Campanelli, F. & Ghiglieri, V. Advances in understanding the function of alpha-synuclein: implications for Parkinson\u2019s disease. Brain 146, 3587\u20133597 (2023).","journal-title":"Brain"},{"key":"1201_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"1201_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert, M., Spillantini, M. G., Del Tredici, K. & Braak, H. 100 years of Lewy pathology. Nat. Rev. Neurol. 9, 13\u201324 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"1201_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel, H. A., Overk, C. R., Oueslati, A. & Masliah, E. The many faces of alpha-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 14, 38\u201348 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"1201_CR14","doi-asserted-by":"publisher","unstructured":"Woerman, A. L. et al. alpha-Synuclein: multiple system atrophy prions. Cold Spring Harb. Perspect. Med. 8, https:\/\/doi.org\/10.1101\/cshperspect.a024588 (2018).","DOI":"10.1101\/cshperspect.a024588"},{"key":"1201_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2018.00080","volume":"12","author":"JC Bridi","year":"2018","unstructured":"Bridi, J. C. & Hirth, F. Mechanisms of alpha-Synuclein Induced Synaptopathy in Parkinson\u2019s Disease. Front. Neurosci. 12, 80 (2018).","journal-title":"Front. Neurosci."},{"key":"1201_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi, P. et al. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 14, 176 (2023).","journal-title":"Cell Death Dis."},{"key":"1201_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer, W. & Przedborski, S. Parkinson\u2019s disease: mechanisms and models. Neuron 39, 889\u2013909 (2003).","journal-title":"Neuron"},{"key":"1201_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0022-510X(02)00006-0","volume":"195","author":"W Marui","year":"2002","unstructured":"Marui, W. et al. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J. Neurol. Sci. 195, 153\u2013159 (2002).","journal-title":"J. Neurol. Sci."},{"key":"1201_CR19","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","volume":"27","author":"ML Kramer","year":"2007","unstructured":"Kramer, M. L. & Schulz-Schaeffer, W. J. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J. Neurosci. 27, 1405\u20131410 (2007).","journal-title":"J. Neurosci."},{"key":"1201_CR20","doi-asserted-by":"publisher","first-page":"626128","DOI":"10.3389\/fncel.2021.626128","volume":"15","author":"NZ Gcwensa","year":"2021","unstructured":"Gcwensa, N. Z., Russell, D. L., Cowell, R. M. & Volpicelli-Daley, L. A. Molecular mechanisms underlying synaptic and axon degeneration in Parkinson\u2019s disease. Front. Cell Neurosci. 15, 626128 (2021).","journal-title":"Front. Cell Neurosci."},{"key":"1201_CR21","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1093\/brain\/awad064","volume":"146","author":"KML Cramb","year":"2023","unstructured":"Cramb, K. M. L., Beccano-Kelly, D., Cragg, S. J. & Wade-Martins, R. Impaired dopamine release in Parkinson\u2019s disease. Brain 146, 3117\u20133132 (2023).","journal-title":"Brain"},{"key":"1201_CR22","doi-asserted-by":"publisher","first-page":"fcac165","DOI":"10.1093\/braincomms\/fcac165","volume":"4","author":"AS Kulkarni","year":"2022","unstructured":"Kulkarni, A. S., Burns, M. R., Brundin, P. & Wesson, D. W. Linking alpha-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson\u2019s disease. Brain Commun. 4, fcac165 (2022).","journal-title":"Brain Commun."},{"key":"1201_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00401-019-02010-2","volume":"138","author":"J Alegre-Abarrategui","year":"2019","unstructured":"Alegre-Abarrategui, J. et al. Selective vulnerability in alpha-synucleinopathies. Acta Neuropathol. 138, 681\u2013704 (2019).","journal-title":"Acta Neuropathol."},{"key":"1201_CR24","doi-asserted-by":"publisher","first-page":"580634","DOI":"10.3389\/fcell.2020.580634","volume":"8","author":"G Minakaki","year":"2020","unstructured":"Minakaki, G., Krainc, D. & Burbulla, L. F. The convergence of Alpha-synuclein, mitochondrial, and lysosomal pathways in vulnerability of midbrain dopaminergic neurons in Parkinson\u2019s disease. Front. Cell Dev. Biol. 8, 580634 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1201_CR25","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.neuron.2019.03.004","volume":"101","author":"MM McGregor","year":"2019","unstructured":"McGregor, M. M. & Nelson, A. B. Circuit mechanisms of Parkinson\u2019s disease. Neuron 101, 1042\u20131056 (2019).","journal-title":"Neuron"},{"key":"1201_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.cell.2018.01.008","volume":"172","author":"C Liu","year":"2018","unstructured":"Liu, C., Kershberg, L., Wang, J., Schneeberger, S. & Kaeser, P. S. Dopamine secretion is mediated by sparse active zone-like release sites. Cell 172, 706\u2013718.e715 (2018).","journal-title":"Cell"},{"key":"1201_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.tins.2007.03.008","volume":"30","author":"DJ Surmeier","year":"2007","unstructured":"Surmeier, D. J., Ding, J., Day, M., Wang, Z. & Shen, W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 30, 228\u2013235 (2007).","journal-title":"Trends Neurosci."},{"key":"1201_CR28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/0306-4522(94)00536-E","volume":"65","author":"KK Yung","year":"1995","unstructured":"Yung, K. K. et al. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65, 709\u2013730 (1995).","journal-title":"Neuroscience"},{"key":"1201_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","volume":"34","author":"CR Gerfen","year":"2011","unstructured":"Gerfen, C. R. & Surmeier, D. J. Modulation of striatal projection systems by dopamine. Annu Rev. Neurosci. 34, 441\u2013466 (2011).","journal-title":"Annu Rev. Neurosci."},{"key":"1201_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11846","volume":"494","author":"G Cui","year":"2013","unstructured":"Cui, G. et al. Concurrent activation of striatal direct and indirect pathways during action initiation. Nature 494, 238\u2013242 (2013).","journal-title":"Nature"},{"key":"1201_CR31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nature18942","volume":"535","author":"MW Howe","year":"2016","unstructured":"Howe, M. W. & Dombeck, D. A. Rapid signalling in distinct dopaminergic axons during locomotion and reward. Nature 535, 505\u2013510 (2016).","journal-title":"Nature"},{"key":"1201_CR32","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949\u2013953 (2012).","journal-title":"Science"},{"key":"1201_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","volume":"65","author":"VM Nemani","year":"2010","unstructured":"Nemani, V. M. et al. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66\u201379 (2010).","journal-title":"Neuron"},{"key":"1201_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41531-021-00210-w","volume":"7","author":"A Dagra","year":"2021","unstructured":"Dagra, A. et al. alpha-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability. NPJ Parkinsons Dis. 7, 76 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"1201_CR35","doi-asserted-by":"publisher","unstructured":"Hill, E., Gowers, R., Richardson, M. J. E. & Wall, M. J. alpha-Synuclein aggregates increase the conductance of substantia nigra dopamine neurons, an effect partly reversed by the KATP channel inhibitor glibenclamide. eNeuro 8, https:\/\/doi.org\/10.1523\/ENEURO.0330-20.2020 (2021).","DOI":"10.1523\/ENEURO.0330-20.2020"},{"key":"1201_CR36","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1093\/brain\/awab242","volume":"144","author":"A Tozzi","year":"2021","unstructured":"Tozzi, A. et al. Dopamine-dependent early synaptic and motor dysfunctions induced by alpha-synuclein in the nigrostriatal circuit. Brain 144, 3477\u20133491 (2021).","journal-title":"Brain"},{"key":"1201_CR37","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/brain\/awz065","volume":"142","author":"V Durante","year":"2019","unstructured":"Durante, V. et al. Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration. Brain 142, 1365\u20131385 (2019).","journal-title":"Brain"},{"key":"1201_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41583-020-00416-6","volume":"22","author":"MB Fares","year":"2021","unstructured":"Fares, M. B., Jagannath, S. & Lashuel, H. A. Reverse engineering Lewy bodies: how far have we come and how far can we go?. Nat. Rev. Neurosci. 22, 111\u2013131 (2021).","journal-title":"Nat. Rev. Neurosci."},{"key":"1201_CR39","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1002\/cpns.88","volume":"91","author":"M Airavaara","year":"2020","unstructured":"Airavaara, M. et al. Back and to the future: from neurotoxin-induced to human Parkinson\u2019s disease models. Curr. Protoc. Neurosci. 91, e88 (2020).","journal-title":"Curr. Protoc. Neurosci."},{"key":"1201_CR40","doi-asserted-by":"publisher","first-page":"e3001578","DOI":"10.1371\/journal.pbio.3001578","volume":"20","author":"M Berard","year":"2022","unstructured":"Berard, M. et al. A light-inducible protein clustering system for in vivo analysis of alpha-synuclein aggregation in Parkinson disease. PLoS Biol. 20, e3001578 (2022).","journal-title":"PLoS Biol."},{"key":"1201_CR41","doi-asserted-by":"publisher","first-page":"102738","DOI":"10.1016\/j.xpro.2023.102738","volume":"4","author":"M Teixeira","year":"2023","unstructured":"Teixeira, M., Sheta, R., Idi, W. & Oueslati, A. Optogenetic-mediated induction and monitoring of alpha-synuclein aggregation in cellular models of Parkinson\u2019s disease. STAR Protoc. 4, 102738 (2023).","journal-title":"STAR Protoc."},{"key":"1201_CR42","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.neuron.2017.08.015","volume":"95","author":"A Klaus","year":"2017","unstructured":"Klaus, A. et al. The Spatiotemporal organization of the striatum encodes action space. Neuron 95, 1171\u20131180 e1177 (2017).","journal-title":"Neuron"},{"key":"1201_CR43","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neuron.2016.08.037","volume":"92","author":"G Barbera","year":"2016","unstructured":"Barbera, G. et al. Spatially compact neural clusters in the dorsal striatum encode locomotion relevant information. Neuron 92, 202\u2013213 (2016).","journal-title":"Neuron"},{"key":"1201_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41586-018-0090-6","volume":"557","author":"JG Parker","year":"2018","unstructured":"Parker, J. G. et al. Diametric neural ensemble dynamics in parkinsonian and dyskinetic states. Nature 557, 177\u2013182 (2018).","journal-title":"Nature"},{"key":"1201_CR45","doi-asserted-by":"publisher","unstructured":"Maltese, M., March, J. R., Bashaw, A. G. & Tritsch, N. X. Dopamine differentially modulates the size of projection neuron ensembles in the intact and dopamine-depleted striatum. Elife 10, https:\/\/doi.org\/10.7554\/eLife.68041 (2021).","DOI":"10.7554\/eLife.68041"},{"key":"1201_CR46","first-page":"149","volume":"183","author":"DJ Surmeier","year":"2010","unstructured":"Surmeier, D. J. et al. The role of dopamine in modulating the structure and function of striatal circuits. Prog. Brain Res. 183, 149\u2013167 (2010).","journal-title":"Prog. Brain Res."},{"key":"1201_CR47","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/brain\/awn340","volume":"132","author":"P Calabresi","year":"2009","unstructured":"Calabresi, P., Mercuri, N. B. & Di Filippo, M. Synaptic plasticity, dopamine and Parkinson\u2019s disease: one step ahead. Brain 132, 285\u2013287 (2009).","journal-title":"Brain"},{"key":"1201_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tins.2007.03.001","volume":"30","author":"P Calabresi","year":"2007","unstructured":"Calabresi, P., Picconi, B., Tozzi, A. & Di Filippo, M. Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci. 30, 211\u2013219 (2007).","journal-title":"Trends Neurosci."},{"key":"1201_CR49","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.tins.2022.05.001","volume":"45","author":"A Bose","year":"2022","unstructured":"Bose, A., Petsko, G. A. & Studer, L. Induced pluripotent stem cells: a tool for modeling Parkinson\u2019s disease. Trends Neurosci. 45, 608\u2013620 (2022).","journal-title":"Trends Neurosci."},{"key":"1201_CR50","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785\u2013798 (2013).","journal-title":"Neuron"},{"key":"1201_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22158-4","volume":"12","author":"R Sheta","year":"2022","unstructured":"Sheta, R. et al. Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons. Sci. Rep. 12, 17176 (2022).","journal-title":"Sci. Rep."},{"key":"1201_CR52","doi-asserted-by":"publisher","first-page":"102486","DOI":"10.1016\/j.xpro.2023.102486","volume":"4","author":"R Sheta","year":"2023","unstructured":"Sheta, R., Teixeira, M., Idi, W. & Oueslati, A. Optimized protocol for the generation of functional human induced-pluripotent-stem-cell-derived dopaminergic neurons. STAR Protoc. 4, 102486 (2023).","journal-title":"STAR Protoc."},{"key":"1201_CR53","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1074\/jbc.M008919200","volume":"276","author":"BI Giasson","year":"2001","unstructured":"Giasson, B. I., Murray, I. V., Trojanowski, J. Q. & Lee, V. M. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J. Biol. Chem. 276, 2380\u20132386 (2001).","journal-title":"J. Biol. Chem."},{"key":"1201_CR54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","volume":"33","author":"LL Venda","year":"2010","unstructured":"Venda, L. L., Cragg, S. J., Buchman, V. L. & Wade-Martins, R. alpha-Synuclein and dopamine at the crossroads of Parkinson\u2019s disease. Trends Neurosci. 33, 559\u2013568 (2010).","journal-title":"Trends Neurosci."},{"key":"1201_CR55","doi-asserted-by":"publisher","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","volume":"114","author":"P Thakur","year":"2017","unstructured":"Thakur, P. et al. Modeling Parkinson\u2019s disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain. Proc. Natl. Acad. Sci. USA 114, E8284\u2013E8293 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1201_CR56","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake, M. et al. Prion-like spreading of pathological alpha-synuclein in brain. Brain 136, 1128\u20131138 (2013).","journal-title":"Brain"},{"key":"1201_CR57","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1006\/nbdi.2001.0392","volume":"8","author":"Y Matsuoka","year":"2001","unstructured":"Matsuoka, Y. et al. Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol. Dis. 8, 535\u2013539 (2001).","journal-title":"Neurobiol. Dis."},{"key":"1201_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"1201_CR59","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li, J. Y. et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat. Med. 14, 501\u2013503 (2008).","journal-title":"Nat. Med."},{"key":"1201_CR60","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23747","volume":"72","author":"EC Freundt","year":"2012","unstructured":"Freundt, E. C. et al. Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport. Ann. Neurol. 72, 517\u2013524 (2012).","journal-title":"Ann. Neurol."},{"key":"1201_CR61","doi-asserted-by":"publisher","first-page":"17186","DOI":"10.1523\/JNEUROSCI.2220-12.2012","volume":"32","author":"Y Nakata","year":"2012","unstructured":"Nakata, Y. et al. Accumulation of alpha-synuclein triggered by presynaptic dysfunction. J. Neurosci. 32, 17186\u201317196 (2012).","journal-title":"J. Neurosci."},{"key":"1201_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06724-9","volume":"7","author":"JA Phan","year":"2017","unstructured":"Phan, J. A. et al. Early synaptic dysfunction induced by alpha-synuclein in a rat model of Parkinson\u2019s disease. Sci. Rep. 7, 6363 (2017).","journal-title":"Sci. Rep."},{"key":"1201_CR63","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1093\/brain\/awx275","volume":"140","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena, M. et al. Synaptic phosphorylated alpha-synuclein in dementia with Lewy bodies. Brain 140, 3204\u20133214 (2017).","journal-title":"Brain"},{"key":"1201_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-023-01059-1","volume":"16","author":"D Perez-Acuna","year":"2023","unstructured":"Perez-Acuna, D., Shin, S. J., Rhee, K. H., Kim, S. J. & Lee, S. J. alpha-Synuclein propagation leads to synaptic abnormalities in the cortex through microglial synapse phagocytosis. Mol. Brain 16, 72 (2023).","journal-title":"Mol. Brain"},{"key":"1201_CR65","doi-asserted-by":"publisher","first-page":"E3679","DOI":"10.1073\/pnas.1617259114","volume":"114","author":"G Kouroupi","year":"2017","unstructured":"Kouroupi, G. et al. Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson\u2019s disease. Proc. Natl. Acad. Sci. USA 114, E3679\u2013E3688 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1201_CR66","doi-asserted-by":"publisher","first-page":"106595","DOI":"10.1016\/j.nbd.2024.106595","volume":"199","author":"NZ Gcwensa","year":"2024","unstructured":"Gcwensa, N. Z. et al. Excitatory synaptic structural abnormalities produced by templated aggregation of alpha-syn in the basolateral amygdala. Neurobiol. Dis. 199, 106595 (2024).","journal-title":"Neurobiol. Dis."},{"key":"1201_CR67","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.expneurol.2017.10.002","volume":"298","author":"J Blesa","year":"2017","unstructured":"Blesa, J. et al. Compensatory mechanisms in Parkinson\u2019s disease: Circuits adaptations and role in disease modification. Exp. Neurol. 298, 148\u2013161 (2017).","journal-title":"Exp. Neurol."},{"key":"1201_CR68","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1523\/JNEUROSCI.2898-12.2013","volume":"33","author":"D Boassa","year":"2013","unstructured":"Boassa, D. et al. Mapping the subcellular distribution of alpha-synuclein in neurons using genetically encoded probes for correlated light and electron microscopy: implications for Parkinson\u2019s disease pathogenesis. J. Neurosci. 33, 2605\u20132615 (2013).","journal-title":"J. Neurosci."},{"key":"1201_CR69","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0092-8674(85)80082-9","volume":"41","author":"B Wiedenmann","year":"1985","unstructured":"Wiedenmann, B. & Franke, W. W. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41, 1017\u20131028 (1985).","journal-title":"Cell"},{"key":"1201_CR70","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1073\/pnas.82.12.4137","volume":"82","author":"R Jahn","year":"1985","unstructured":"Jahn, R., Schiebler, W., Ouimet, C. & Greengard, P. A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc. Natl. Acad. Sci. USA 82, 4137\u20134141 (1985).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1201_CR71","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.1523\/JNEUROSCI.1091-10.2010","volume":"30","author":"DA Scott","year":"2010","unstructured":"Scott, D. A. et al. A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration. J. Neurosci. 30, 8083\u20138095 (2010).","journal-title":"J. Neurosci."},{"key":"1201_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.celrep.2016.12.023","volume":"18","author":"KJ Vargas","year":"2017","unstructured":"Vargas, K. J. et al. Synucleins Have Multiple Effects on Presynaptic Architecture. Cell Rep. 18, 161\u2013173 (2017).","journal-title":"Cell Rep."},{"key":"1201_CR73","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40478-018-0537-x","volume":"6","author":"JM Froula","year":"2018","unstructured":"Froula, J. M. et al. alpha-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons. Acta Neuropathol. Commun. 6, 35 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"1201_CR74","doi-asserted-by":"publisher","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","volume":"110","author":"S Janezic","year":"2013","unstructured":"Janezic, S. et al. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc. Natl. Acad. Sci. USA 110, E4016\u2013E4025 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1201_CR75","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1073\/pnas.93.10.5166","volume":"93","author":"JD Erickson","year":"1996","unstructured":"Erickson, J. D., Schafer, M. K., Bonner, T. I., Eiden, L. E. & Weihe, E. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc. Natl. Acad. Sci. USA 93, 5166\u20135171 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1201_CR76","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fnmol.2018.00467","volume":"11","author":"N Umek","year":"2018","unstructured":"Umek, N., Gersak, B., Vintar, N., Sostaric, M. & Mavri, J. Dopamine Autoxidation is controlled by acidic pH. Front. Mol. Neurosci. 11, 467 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"1201_CR77","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1073\/pnas.93.5.1956","volume":"93","author":"TG Hastings","year":"1996","unstructured":"Hastings, T. G., Lewis, D. A. & Zigmond, M. J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA 93, 1956\u20131961 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1201_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-11-34","volume":"11","author":"J Meiser","year":"2013","unstructured":"Meiser, J., Weindl, D. & Hiller, K. Complexity of dopamine metabolism. Cell Commun. Signal. 11, 34 (2013).","journal-title":"Cell Commun. Signal."},{"key":"1201_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02233-0","volume":"12","author":"H Xu","year":"2022","unstructured":"Xu, H. & Yang, F. The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia. Transl. Psychiatry 12, 464 (2022).","journal-title":"Transl. Psychiatry"},{"key":"1201_CR80","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1073\/pnas.1218424110","volume":"110","author":"BK Choi","year":"2013","unstructured":"Choi, B. K. et al. Large alpha-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking. Proc. Natl. Acad. Sci. USA 110, 4087\u20134092 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1201_CR81","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.tins.2018.07.004","volume":"41","author":"CV Cosme","year":"2018","unstructured":"Cosme, C. V., Palissery, G. K. & Lerner, T. N. A dLight-ful New View of Neuromodulation. Trends Neurosci. 41, 566\u2013568 (2018).","journal-title":"Trends Neurosci."},{"key":"1201_CR82","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/s41592-020-0936-3","volume":"17","author":"T Patriarchi","year":"2020","unstructured":"Patriarchi, T. et al. An expanded palette of dopamine sensors for multiplex imaging in vivo. Nat. Methods 17, 1147\u20131155 (2020).","journal-title":"Nat. Methods"},{"key":"1201_CR83","doi-asserted-by":"publisher","unstructured":"Patriarchi, T. et al. Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors. Science 360, https:\/\/doi.org\/10.1126\/science.aat4422 (2018).","DOI":"10.1126\/science.aat4422"},{"key":"1201_CR84","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.neuro.051508.135422","volume":"32","author":"AC Kreitzer","year":"2009","unstructured":"Kreitzer, A. C. Physiology and pharmacology of striatal neurons. Annu. Rev. Neurosci. 32, 127\u2013147 (2009).","journal-title":"Annu. Rev. Neurosci."},{"key":"1201_CR85","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0006-8993(85)91524-0","volume":"327","author":"GA Graveland","year":"1985","unstructured":"Graveland, G. A. & DiFiglia, M. The frequency and distribution of medium-sized neurons with indented nuclei in the primate and rodent neostriatum. Brain Res. 327, 307\u2013311 (1985).","journal-title":"Brain Res."},{"key":"1201_CR86","doi-asserted-by":"publisher","first-page":"112204","DOI":"10.1016\/j.celrep.2023.112204","volume":"42","author":"N Chuhma","year":"2023","unstructured":"Chuhma, N., Oh, S. J. & Rayport, S. The dopamine neuron synaptic map in the striatum. Cell Rep. 42, 112204 (2023).","journal-title":"Cell Rep."},{"key":"1201_CR87","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnana.2011.00031","volume":"5","author":"ML Perreault","year":"2011","unstructured":"Perreault, M. L., Hasbi, A., O\u2019Dowd, B. F. & George, S. R. The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia. Front. Neuroanat. 5, 31 (2011).","journal-title":"Front. Neuroanat."},{"key":"1201_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40677-0","volume":"14","author":"C Varin","year":"2023","unstructured":"Varin, C., Cornil, A., Houtteman, D., Bonnavion, P. & de Kerchove d\u2019Exaerde, A. The respective activation and silencing of striatal direct and indirect pathway neurons support behavior encoding. Nat. Commun. 14, 4982 (2023).","journal-title":"Nat. Commun."},{"key":"1201_CR89","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fnana.2011.00043","volume":"5","author":"A Nishi","year":"2011","unstructured":"Nishi, A., Kuroiwa, M. & Shuto, T. Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neurons. Front. Neuroanat. 5, 43 (2011).","journal-title":"Front. Neuroanat."},{"key":"1201_CR90","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-neuro-072116-031033","volume":"42","author":"A Klaus","year":"2019","unstructured":"Klaus, A., Alves da Silva, J. & Costa, R. M. What, if, and when to move: basal ganglia circuits and self-paced action initiation. Annu. Rev. Neurosci. 42, 459\u2013483 (2019).","journal-title":"Annu. Rev. Neurosci."},{"key":"1201_CR91","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41531-022-00366-z","volume":"8","author":"S Stern","year":"2022","unstructured":"Stern, S. et al. Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson\u2019s disease patients. NPJ Parkinsons Dis. 8, 103 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1201_CR92","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41531-022-00423-7","volume":"8","author":"GS Virdi","year":"2022","unstructured":"Virdi, G. S. et al. Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson\u2019s disease in midbrain dopaminergic neurons. NPJ Parkinsons Dis. 8, 162 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1201_CR93","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41593-018-0209-y","volume":"21","author":"A Mathis","year":"2018","unstructured":"Mathis, A. et al. DeepLabCut: markerless pose estimation of user-defined body parts with deep learning. Nat. Neurosci. 21, 1281\u20131289 (2018).","journal-title":"Nat. Neurosci."},{"key":"1201_CR94","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/s41596-019-0176-0","volume":"14","author":"T Nath","year":"2019","unstructured":"Nath, T. et al. Using DeepLabCut for 3D markerless pose estimation across species and behaviors. Nat. Protoc. 14, 2152\u20132176 (2019).","journal-title":"Nat. Protoc."},{"key":"1201_CR95","unstructured":"Paxinos, G., Franklin, K. B. J. & Franklin, K. B. J. The mouse brain in stereotaxic coordinates. 2nd edn, (Academic Press, 2001)."},{"key":"1201_CR96","doi-asserted-by":"publisher","first-page":"e1009471","DOI":"10.1371\/journal.pgen.1009471","volume":"17","author":"AE Ikui","year":"2021","unstructured":"Ikui, A. E., Ueki, N., Pecani, K. & Cross, F. R. Control of pre-replicative complex during the division cycle in Chlamydomonas reinhardtii. PLoS Genet. 17, e1009471 (2021).","journal-title":"PLoS Genet."},{"key":"1201_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49712-0","volume":"15","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. Development of a genetically encoded sensor for probing endogenous nociceptin opioid peptide release. Nat. Commun. 15, 5353 (2024).","journal-title":"Nat. Commun."},{"key":"1201_CR98","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1021\/acschemneuro.4c00274","volume":"15","author":"HT Evans","year":"2024","unstructured":"Evans, H. T. et al. Light-Activatable, cell-type specific labeling of the nascent proteome. ACS Chem. Neurosci. 15, 3473\u20133481 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"1201_CR99","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0304-3940(99)00411-5","volume":"269","author":"R Jakes","year":"1999","unstructured":"Jakes, R. et al. Epitope mapping of LB509, a monoclonal antibody directed against human alpha-synuclein. Neurosci. Lett. 269, 13\u201316 (1999).","journal-title":"Neurosci. Lett."},{"key":"1201_CR100","doi-asserted-by":"publisher","unstructured":"Russo, E. E. et al. Evaluation and validation of commercially available dopamine transporter antibodies. eNeuro 10, https:\/\/doi.org\/10.1523\/ENEURO.0341-22.2023 (2023).","DOI":"10.1523\/ENEURO.0341-22.2023"},{"key":"1201_CR101","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/cac2.12103","volume":"40","author":"Y Yan","year":"2020","unstructured":"Yan, Y. et al. Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma. Cancer Commun. 40, 694\u2013710 (2020).","journal-title":"Cancer Commun."},{"key":"1201_CR102","doi-asserted-by":"publisher","unstructured":"Bhowmick, S. et al. Intercellular adhesion molecule-1-induced posttraumatic brain injury neuropathology in the prefrontal cortex and hippocampus leads to sensorimotor function deficits and psychological stress. eNeuro 8, https:\/\/doi.org\/10.1523\/ENEURO.0242-21.2021 (2021).","DOI":"10.1523\/ENEURO.0242-21.2021"},{"key":"1201_CR103","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan, Y. et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 160, 62\u201373 (2015).","journal-title":"Cell"},{"key":"1201_CR104","doi-asserted-by":"publisher","first-page":"111748","DOI":"10.1016\/j.biopha.2021.111748","volume":"140","author":"X She","year":"2021","unstructured":"She, X., Gao, Y., Zhao, Y., Yin, Y. & Dong, Z. A high-throughput screen identifies inhibitors of lung cancer stem cells. Biomed. Pharmacother. 140, 111748 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"1201_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/srep46280","volume":"7","author":"P Illiano","year":"2017","unstructured":"Illiano, P. et al. Recombinant adeno-associated virus-mediated rescue of function in a mouse model of dopamine transporter deficiency syndrome. Sci. Rep. 7, 46280 (2017).","journal-title":"Sci. Rep."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01201-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01201-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01201-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T13:02:40Z","timestamp":1766581360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01201-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01201-x","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}